VOTRIENT
- Product NDC
- 0078-0670
- 11-digit product format
- 000780670
- Labeler code
- 0078
- Product ID
- 0078-0670_d64a4078-2cff-48a7-a621-c31d82703ae6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pazopanib hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA022465
- Marketing category
- NDA
- Marketing start
- 2016-07-12
- Marketing end
- 0000-00-00
- Substance
- PAZOPANIB HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0670-66 | 00078067066 | 120 TABLET, FILM COATED in 1 BOTTLE (0078-0670-66) | 2016-07-12 | 0000-00-00 | No | No | Current |